hepatitis if hepatitis c not hcv for livers and diseases the treatments for symptoms if remedies or remedys the hepatitis c |
 |
Your Complete Guide To Hepatitis C
Separating
Fact From Fiction
|
|
Your Complete Guide To Hepatitis C
by Phil Allard
|
From: Dean Brenner
Date: Tuesday, December 2, 2008 |
| |
|
Have you or a loved one been recently diagnosed with Hepatitis C? If so, you
probably already know that it targets the liver. What you may not know is that
more than four million people around the world are victims of Hepatitis
C.
There are some serious considerations when you are diagnosed with Hepatitis
C but there are also serious misconceptions. Did you know that it is an infection?
To be accurate it is blood-borne virus, HCV.
Hepatitis C is spread through contact with the blood of someone who is already
infected. in fact, what makes this infectious disease so insidious is that treatment
is often overlooked because the patient does not experience serious symptoms until
well after the acute stage.
Sadly, diagnosis usually does not occur until extensive liver damage has already
occurred. This is why early detection is so vital. The bottom line here is that
we all need to be aware of this condition.
Your Complete Guide To Hepatitis C gives you the answers to the tough
questions - even to the questions you don't know to ask, like some of these:
- What is Hepatitis C?
- What causes Hepatitis C infection.
- What are the first symptoms of HCV infection?
- How can people get infected with HCV?
- What medical complications can Hepatitis C cause?
- Who can get Hepatitis C infection?
- Is there any vaccination for Hepatitis C?
- What are the treatment options for Hepatitis C?
- What are preventive measures for Hepatitis C infection?
- Can an HCV-infected Mother pass on line?
- Can Hepatitis C spread through sexual contact?
- Can an HCV-infected person donate blood?
- How is it spread?
- What about tattoos and piercings?
All About Women and Hepatitis C
Do you know all about how Hepatitis C interacts with menstruation, pregnancy
and contraception? There is an entire chapter devoted to just this topic.
You need answers to these and the multitude of other questions if you are to
be armed with the right ammunition when suspecting the blood-borne infection in
yourself or a loved one.
Early diagnosis is crucial! Waiting can be extremely serious and is not recommended.
Each day that you delay causes more and more danger. Get it done and get it done
now!
Your Complete Guide To Hepatitis C is no replacement for medical advice
and should not be construed as such. Rather, it is a valuable tool to arm yourself
with important information regarding the diagnosis and treatment of this disorder.
Remember, Hepatitis C is not a mental illness. Yes it is contagious. But good
personal hygiene is a tool against the risk!
Again, if you or a loved one suspects they have Hepatitis or are diagnosed
with it, you need answers.
Your Complete Guide To Hepatitis C is just what you need to become informed.
Order your copy now and have your answers in minutes!
Phil Allard (Author) |
hepatitis the hepatitis c when hcv then livers the diseases but treatments maybe symptoms as remedies because remedys as hepatitis c |
| |
|
|
| |
| |
|
|
| |
| |
 |
| |
| |
Our 365-day Guarantee! If you're not 100% completely satisfied, we'll
return 100% of everything you paid.
It's the best guarantee in the business!
We want you to be a happy customer ... If for any reason you are not completely satisfied with the Your Complete Guide To Hepatitis C,
just drop us a line (our full details are at the bottom of this page) with a copy of your sales receipt and we'll gladly refund your
full purchase amount. No questions asked ... No hassles ... And we can still be friends...
Now that's more than a guarantee ... It's our personal promise to you. |
| |
| |
|
| |
| |
Here are two easy ways to order:
Order
Your Complete Guide To Hepatitis C online
... immediate download Order Your Complete Guide To Hepatitis C by mail
|
| |
|
| |
| |
| |
To your success!
Dean Brenner
Webmaster
BWS Group |
| |
| |
| P.S. Please do not order this product if you're looking for a fat book
full of fluff. What you'll get is a mini manual of high quality information that
is written by an e-commerce industry expert, who has put all these methods into
practice.
He has had successes and failures in e-commerce and has been fortunate enough
to have created a multi-million dollar web business from his home office.
|
| |
| |
|
|
| |
| |
|
|
| |
| |
| |
| Check Out These Other Great Health Related Titles Click a title to visit the product website* |
| |
* Note: A new browser window will open. When finished viewing,
close the new browser window and you will be returned here. |
|
| |
Click a title to visit the product website*
|
| | | | |
Do you need more Health-Related information?
Take a look at Improve Your Life. You will be sure to find it there ...
and at a nice bargain-basement price as well.
|
| |
* Note: A new browser window will open. When finished viewing,
close the new browser window and you will be returned here. |
|
| | | |
|
|
| |
| |
|
| |
| |
|
|
| |
|
|
| |
| |
| Liver Disease / Hepatitis News Informational Articles |
| |
Tue, 02 Dec 2008 00:00:00 PST
Mayo Clinic Seeks New Therapies For Alcoholic Hepatitis
A new study from Mayo Clinic finds the use of the drug therapy etanercept ineffective in treating alcoholic hepatitis, an acute inflammation of the liver caused by excessive consumption of alcohol. The results of the study are published in the December issue of Gastroenterology (http://www.gastrojournal.org). Alcoholic hepatitis is a major cause of morbidity and mortality worldwide. | | | Mon, 01 Dec 2008 04:00:00 PST
Bariatric Surgery May Resolve Liver Disease
Obesity is a growing epidemic in the U.S. with a significant increase in prevalence from 15 percent to 32.9 percent from 1980 to 2004. Nonalcoholic fatty liver disease (NAFLD) is an emerging problem related to the obesity epidemic, becoming one of the most common causes of liver disease in the nation. Bariatric surgery has become a popular and effective method for rapid and permanent significant weight loss in morbidly obese individuals. | | | Fri, 28 Nov 2008 01:00:00 PST
Indiana Addresses Viral Hepatitis
State health officials say between 3.5 to 4 million Americans are living with viral hepatitis. In 2006, there were 4,723 reported cases of chronic and acute hepatitis C in Indiana, as well as 80 cases of hepatitis B, 33 cases of hepatitis A, and one case of hepatitis E. To address the problem in the state, the Indiana Viral Hepatitis Advisory Council has released "Indiana's Strategic Plan for the Prevention, Care, and Elimination of Viral Hepatitis. | | | Fri, 28 Nov 2008 00:00:00 PST
New System Eliminates Racial Disparities In Liver Transplants
A new system for determining eligibility for liver transplants has improved black liver patients' chances of receiving the life-saving treatment, according to a study in this week's Journal of the American Medical Association, the AP/Houston Chronicle reports. | | | Wed, 26 Nov 2008 00:00:00 PST
Light Sciences Oncology Completes Patient Enrollment In Phase 3 Clinical Trial Of Litx As A Treatment For Hepatocellular Carcinoma
Light Sciences Oncology, Inc. (LSO) announced the completion of enrollment in a global Phase 3 clinical trial of Light Infusion Therapy(TM) (Litx(TM)) as a treatment for unresectable hepatocellular carcinoma (HCC), also known as hepatoma or primary liver cancer. The two-armed, randomized clinical trial has enrolled 200 patients at sites in the Philippines, Korea, India, Malaysia, Thailand, Hong Kong, Singapore, Serbia, Poland, Croatia, and Italy. | | | Tue, 25 Nov 2008 00:00:00 PST
Schering Plough Provides Update On Boceprevir Clinical Development And Introduces Potent Next Generation Oral HCV Protease Inhibitor
Schering-Plough Corporation (NYSE: SGP) provided a clinical update on boceprevir, its lead investigational oral hepatitis C protease inhibitor currently in Phase III development. The company believes boceprevir has the potential to be a first-in-class and best-in-class protease inhibitor for treating chronic hepatitis C. The company also announced that it is developing a highly potent next-generation oral hepatitis C protease inhibitor that has future best-in-class potential. | | | Thu, 20 Nov 2008 09:00:00 PST
Bovie Medical Corporation Announces FDA 510(K) Clearance To Market SEER Tissue Resection Device
Bovie Medical Corporation (the "Company") (NYSE Alternext US: BVX), a manufacturer and marketer of electrosurgical products, today announced the Company received 510(k) clearance from the Food and Drug Administration (FDA) to market its SEER tissue resection device intended for initial use in liver oncology surgery. The SEER device uses conductive sintered steel as an electrode for radio frequency (RF) for cutting and coagulation. | | | Thu, 20 Nov 2008 03:00:00 PST
Investigational Genotype 1 Hepatitis C Treatment, TMC435 - Promising Study Results
New clinical data demonstrate the safety and antiviral activity of TMC435, an investigational protease inhibitor (PI) being developed by Tibotec BVBA for the treatment of chronic hepatitis C virus (HCV) infection. | | | Thu, 20 Nov 2008 03:00:00 PST
Tibotec Begins European Enrollment For Phase 3 Trial Of Telaprevir In HCV Patients Who Failed Prior Treatment
Tibotec BVBA today announced that it has begun enrolling patients in its phase III study of telaprevir (VX-950), an investigational protease inhibitor (PI), in patients with chronic genotype 1 hepatitis C virus (HCV) for whom the current standard treatment has not been successful. Tibotec is managing the global trial, which is being conducted at more than 50 sites in Europe. | | | Wed, 19 Nov 2008 03:00:00 PST
13 New Tumor-Suppressor Genes In Liver Cancer Identified By Cold Spring Harbor Science Teams
Over the years, hunting for cancer-related genes and understanding how they work has been an important, although time-consuming, exercise. At Cold Spring Harbor Laboratory (CSHL), five different research groups have now combined their expertise to speed up the rate of discovering cancer-related genes and validating their function in living animals. | | |
|
| |
|
| |
| |
| * Any testimonials and/or examples used may be exceptional results which may not apply to the average person.
They are not intended to represent or guarantee that anyone who purchases and/or uses this product will acheive the same or similar
results. Each individual's success depends on their background, dedication, desire and motivation. |
bonus points
